Related Experiment Video
Updated: May 21, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Relationship Between the Aggregate Index of Systemic Inflammation and the prognosis in Patients With CAD and CKD
Tian Chang1,2, Yibo He3,4, Yihang Ling4
1School of Medicine, South China University of Technology, Guangzhou, China.
Insights
The Aggregate Index of Systemic Inflammation (AISI) predicts mortality in patients with coronary artery disease (CAD) and chronic kidney disease (CKD). Higher AISI levels are linked to increased risks of all-cause and cardiovascular death.
Area of Science:
- Cardiology
- Nephrology
- Inflammation Research
Background:
- Coronary artery disease (CAD) and chronic kidney disease (CKD) often coexist, worsening systemic inflammation.
- The predictive capability of the Aggregate Index of Systemic Inflammation (AISI) in this dual-condition population is not well-established.
Purpose of the Study:
- To investigate the association between AISI levels and mortality outcomes in patients with both CAD and CKD.
- To determine if AISI can serve as a prognostic biomarker in this high-risk group.
Main Methods:
- Analysis of data from the Cardiorenal Improvement II (CIN-II) cohort, including 15,133 patients with CAD and CKD.
- Calculation of AISI using neutrophil, platelet, monocyte, and lymphocyte counts.
- Statistical analysis, including survival analysis with adjustment for confounding factors, over a median follow-up of 4.26 years.
Main Results:
- Elevated AISI levels were significantly associated with increased all-cause mortality (HRs ranging from 1.20 to 1.59 across quartiles).
- Higher AISI levels also correlated with a greater risk of cardiovascular mortality (HRs ranging from 1.27 to 1.78 across quartiles).
- A clear trend (p < 0.001) of increasing mortality risk with higher AISI quartiles was observed for both outcomes.
Conclusions:
- The Aggregate Index of Systemic Inflammation (AISI) is an independent predictor of both all-cause and cardiovascular mortality in patients with comorbid CAD and CKD.
- AISI may be a valuable tool for risk stratification in patients with these combined conditions.
Abstract:
Chronic kidney disease (CKD) is a complex disease that may exacerbate the inflammatory state in patients with coronary artery disease (CAD). The predictive value of the Aggregate Index of Systemic Inflammation (AISI) for individuals with CAD and chronic kidney disease (CKD) remains unclear. The data for this study were obtained from the Cardiorenal Improvement II (CIN-II) cohort. Patients (n = 15,133) with CAD combined with CKD were included. The AISI was calculated using the formula: neutrophil*platelet*monocyte/lymphocyte counts. During a median follow-up of 4.26 years, 3979 deaths occurred, including 2239 cardiovascular (CV) deaths. With adjustment for potential confounding factors, the level of AISI was associated with a higher risk of all-cause mortality (Q [quartile]2, Q3, Q4: hazard ratio [HR] [95 CI%] = 1.20 [1.09-1.32], 1.34 [1.22-1.48], and 1.59 [1.44-1.75], respectively; ptrend < 0.001) and CV mortality (Q2, Q3, Q4: HR [95 CI%] = 1.27 [1.11-1.45], 1.50 [1.32-1.71], 1.78 [1.55-2.03], respectively; ptrend < 0.001). Elevated AISI level was independently associated with increased risks of all-cause and CV-specific mortality in patients with CAD and CKD.
Related Concept Videos
Coronary Artery Disease I: Introduction
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Chronic Inflammation: Introduction